Skip to main content
My Experience
Login Required
Program
Full Program
Browse By Date
Friday, April 22, 2022
Saturday, April 23, 2022
Sunday, April 24, 2022
Browse By Title
Browse By Presenter
CME Program
Non-CME Industry Sessions
Abstracts and ePosters
Browse by Track
Browse by Presenter
Sponsors
Login Required
Attendees
Login Required
CME and Evaluation Information
Login Required
Meeting Info and FAQ
My User Profile
Login Required
Kidney Cancer Association Info
Upcoming IKCS Meetings
Toggle navigation
Login
Search
Home
My Experience
Login Required
Program
Full Program
Browse By Date
Friday, April 22, 2022
Saturday, April 23, 2022
Sunday, April 24, 2022
Browse By Title
Browse By Presenter
CME Program
Non-CME Industry Sessions
Abstracts and ePosters
Browse by Track
Browse by Presenter
Sponsors
Login Required
Attendees
Login Required
CME and Evaluation Information
Login Required
Meeting Info and FAQ
My User Profile
Login Required
Kidney Cancer Association Info
Upcoming IKCS Meetings
Tweets by 2022 IKCS: Europe
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
3 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Carril-Ajuria, Lucia
Institute Gustave Roussy, Villejuif, France. University Hospital 12 de Octubre, Madrid, Spain.
12
:
Efficacy of frontline combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS)
Lucia Carril-Ajuria
Favorite
23
:
Relationship between circulating immune markers and tertiary lymphoid structures (TLS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab within the NIVOREN study.
Lucia Carril-Ajuria
Favorite
24
:
Circulating microRNAs and treatment response to cabozantinib in metastatic clear cell renal cell carcinoma (mRCC) patients treated in the phase II CABOPRE trial.
Lucia Carril-Ajuria
Favorite
Back to Top
